Phase II study of mitomycin C plus 5-fluorouracil in patients with refractory ovarian cancer.
Peláez
I
I
López
R
R
Palacio
I
I
Fernández
Y
Y
Estrada
E
E
Esteban
E
E
Buesa
J M
JM
Lacave
A J
AJ
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D008875:Middle Aged; D016685:Mitomycin / Q000008:administration & dosage* / Q000009:adverse effects; D010051:Ovarian Neoplasms / Q000188:drug therapy*
D016685:Mitomycin; D005472:Fluorouracil